kidney stones and glp-1 Nephroprotective effects of receptor agonists: where do we stand? | Journal of Nephrology The boom in GLP1 drugs

Its about providing care that can improve their lives. Moving toward medications In a dramatic shift in pediatric weight-loss options, the Food and Drug Administration approved a GLP-1 medication the daily injectable liraglutide for kids 12 and up in 2020, and a second the weekly injectable semaglutide in 2022

As estrogen drops during perimenopause and crashes after menopause, your body composition shifts in ways that make weight management harder

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States

Approximately one-half of individuals in these trials did not have diabetes

Movement that doesnt feel like punishment: You dont need to become a gym rat

Ill discuss the most common side effects in this blog